Overview
Howard Li is an Intensive Care Medicine provider in Aurora, Colorado. Dr. Li is highly rated in 1 condition, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
His clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
1665 Aurora Ct Fl 2, Aurora, CO 80045
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of Colorado Hospital Authority
Andrew Fontenot is an Intensive Care Medicine provider in Aurora, Colorado. Dr. Fontenot is highly rated in 9 conditions, according to our data. His top areas of expertise are Beryllium Disease, Sarcoidosis, Neurosarcoidosis, and Interstitial Lung Disease.
National Jewish Health
Irina Petrache is an Intensive Care Medicine provider in Denver, Colorado. Dr. Petrache is highly rated in 13 conditions, according to our data. Her top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, and Pulmonary Hypertension.
National Jewish Health
Gregory Cosgrove is an Intensive Care Medicine provider in Denver, Colorado. Dr. Cosgrove is highly rated in 8 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis.
Frequently Asked Questions about Dr. Howard Li
How do I make an appointment with Dr. Howard Li?
You can book an appointment with Dr. Howard Li by calling their office at 720-848-0000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Howard Li a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Howard Li is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Howard Li specialize in?
While Dr. Howard Li is a Intensive Care Medicine, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Howard Li participate in research or clinical trials?
Yes. Dr. Howard Li has published 36 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Howard Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Howard Li accept my insurance?
Dr. Howard Li accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 720-848-0000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Li isAdvanced. Learn about Lung Cancer.
- Experienced
- Lung AdenocarcinomaDr. Li isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)